Atlas of Human Milk Nutrients

January 4, 2016 updated by: Nestlé

The main objective of this clinical trial is to collect human milk samples from 0 to 4 months after delivery in order to characterize human milk components. The secondary objectives of this study are:

  1. To assess whether there is a correlation between human milk composition and mothers' diet
  2. To assess whether there is a correlation between human milk composition and maternal clinical parameters
  3. To assess whether there is a correlation between human milk composition and mother and infant clinical parameters

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

370

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France
        • CHU Bordeaux
      • Lille, France
        • CHRU de Lille
      • Lyon, France
        • Hôpital de la Croix Rousse
      • Varese, Italy
        • Ospedale Del Ponte
      • Oslo, Norway
        • Oslo University Hospital
      • Braga, Portugal
        • Centro Hospitalar do Alto Ave Guimarães Hospital
      • Braga, Portugal
        • Hospital de São Marcos
      • Porto, Portugal
        • Hospital de S. João
      • Bucharest, Romania
        • Al Jashi Isam Private Med. Practice
      • Bucharest, Romania
        • Polizu Hospital
      • Valencia, Spain
        • Hospital Clinico Universitario de Valencia
      • Stockholm, Sweden, 171 76
        • Department of Woman and Child Health, Karolinska University Hospital
      • Umea, Sweden
        • Umea University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Healthy mothers of any ethnicity having decided to exclusively breast-feed their new born baby from birth up to 4 months of age will be eligible to participate in the study.

Description

Inclusion Criteria:

  • Between 18 and 40 years of age included at time of enrolment
  • BMI before pregnancy between 19 and 29 included
  • Having signed the Informed Consent Form
  • Having decided to exclusively breast-feed until infant is 4 months old

Exclusion Criteria:

  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study
  • Presenting any disease or medical condition which might prevent breast-feeding or collection the human milk samples or for which breast-feeding is not indicated
  • Presenting diseases/medical conditions such as diabetes, heart problems, abnormal conditions of pregnancy (ex. hypertension)
  • Presenting dietary problems/illnesses such as anorexia, bulimia and celiac disease
  • Assuming any medication indicated for the treatment of any metabolic or cardiovascular disease
  • Cannot be expected to comply with the study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Breastfeeding mothers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characterization of human milk components
Time Frame: Between 0 and 4 months after delivery
Nutrients in human breast milk samples will be characterized and quantified by analysing with modern analytical techniques (NMR, HPLC-MS and GC-MS) the human milk samples collected at each study visits (3d, 14 days, 1m, 2m, 3m and 4 months after delivery, 1 week after delivery, ). The parameters which will be assessed in human milk samples are : Total Energy Value, Total Macronutrients (lipids, proteins, carbohydrates, solids), Lipids' characterization, Peptide profiling, Oligosaccharides profiling, and Micro-RNA profiling. It will be done in 240 completed mothers.
Between 0 and 4 months after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Human milk composition versus mothers' diet data
Time Frame: between 3 months before delivery and 4 months after delivery
The human milk composition profiles (primary outcome) will be correlated in a longitudinal manner to mothers' diet. Information on mother's diet will be collected using a 3-days diary and entering the data in Nutrilog (total intake of the mothers). This will be done before each study visit in 240 completed mothers.
between 3 months before delivery and 4 months after delivery
Human milk composition versus maternal clinical parameters
Time Frame: Between 0 and 4 months after delivery
The human milk composition profiles will be correlated in a longitudinal manner to the stage of lactation, the gestation's age, the type of delivery, the sex of the baby, the number of babies the mother already had (gravidity and parity), single/multiple birth. It will be done in 240 completed mothers.
Between 0 and 4 months after delivery
Human milk composition versus mother and infant clinical parameters
Time Frame: Between 0 and 4 months after delivery
The human milk composition profiles will be correlated in a longitudinal manner to infant anthropometric measurements (weight, height and head circumference). It will be done in 240 completed mothers.
Between 0 and 4 months after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Claude Billeaud, Prof, CHU Bordeaux
  • Principal Investigator: Jean-Charles Picaud, Prof, Hôpital de la Croix-Rousse
  • Principal Investigator: Thameur Rakza, Dr, CHRU de Lille
  • Principal Investigator: Massimo Agosti, Dr, Ospedale del Ponte Varese
  • Principal Investigator: Tom Stiris, Dr, Oslo University Hospital
  • Principal Investigator: Silva Gorett, Dr, Hospital de S. João Porto
  • Principal Investigator: Almerinda Barroso Pereira, Dr, Hospital de São Marcos - Braga
  • Principal Investigator: Maria Jose Costeira, Dr, Guimarães Hospital Braga
  • Principal Investigator: Isam Al-Jashi, Dr, Al Jashi Isam Private Med. Practice Bucharest
  • Principal Investigator: Sylvia Stoicescu, Dr, Polizu Hospital Bucharest
  • Principal Investigator: Cecilia Martinez-Costa, Dr, Hospital Clinico Universitario de Valencia
  • Principal Investigator: Magnus Domellöf,, Dr, Umeå University
  • Principal Investigator: Mireille Vanpeé, Dr, Karolinska University Hospital in Solna
  • Principal Investigator: Giovanna Marchini, Dr, Karolinska University Hospital in Solna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

April 25, 2013

First Submitted That Met QC Criteria

July 4, 2013

First Posted (Estimate)

July 10, 2013

Study Record Updates

Last Update Posted (Estimate)

January 5, 2016

Last Update Submitted That Met QC Criteria

January 4, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 11.33.NRC

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding Mothers

Subscribe